677 related articles for article (PubMed ID: 31073761)
1. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
2. Cannabis-based medicines and medical cannabis for adults with cancer pain.
Häuser W; Welsch P; Radbruch L; Fisher E; Bell RF; Moore RA
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014915. PubMed ID: 37283486
[TBL] [Abstract][Full Text] [Related]
3. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
5. A selective review of medical cannabis in cancer pain management.
Blake A; Wan BA; Malek L; DeAngelis C; Diaz P; Lao N; Chow E; O'Hearn S
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S215-S222. PubMed ID: 28866904
[TBL] [Abstract][Full Text] [Related]
6. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
8. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
[TBL] [Abstract][Full Text] [Related]
9. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
Lichtman AH; Lux EA; McQuade R; Rossetti S; Sanchez R; Sun W; Wright S; Kornyeyeva E; Fallon MT
J Pain Symptom Manage; 2018 Feb; 55(2):179-188.e1. PubMed ID: 28923526
[TBL] [Abstract][Full Text] [Related]
10. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
11. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
12. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
14. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
[TBL] [Abstract][Full Text] [Related]
15. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
[TBL] [Abstract][Full Text] [Related]
16. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.
Noori A; Miroshnychenko A; Shergill Y; Ashoorion V; Rehman Y; Couban RJ; Buckley DN; Thabane L; Bhandari M; Guyatt GH; Agoritsas T; Busse JW
BMJ Open; 2021 Jul; 11(7):e047717. PubMed ID: 34321302
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.
Fitzcharles MA; Baerwald C; Ablin J; Häuser W
Schmerz; 2016 Feb; 30(1):47-61. PubMed ID: 26767993
[TBL] [Abstract][Full Text] [Related]
19. The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
Jakubovski E; Pisarenko A; Fremer C; Haas M; May M; Schumacher C; Schindler C; Häckl S; Aguirre Davila L; Koch A; Brunnauer A; Cimpianu CL; Lutz B; Bindila L; Müller-Vahl K
Front Psychiatry; 2020; 11():575826. PubMed ID: 33324255
[No Abstract] [Full Text] [Related]
20. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
